Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 10Recruiting 6Not yet recruiting 5Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 23Head & Neck 6Thoracic 5Breast 5Other solid neoplasm 3Gynecologic 3Tumor-Agnostic 1Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Uterine Cervical Neoplasms 2Recurrence 2Gestational Trophoblastic Disease 1

Interventions

Paclitaxel 264Carboplatin 246Cisplatin 153Bevacizumab 104Gemcitabine 78Topotecan 77liposomal doxorubicin 67pembrolizumab 60Docetaxel 56Cyclophosphamide 50Taxes 48Radiotherapy 44olaparib 43Surveys and Questionnaires 43Doxorubicin 43Filgrastim 42Brachytherapy 37Drug Therapy 31niraparib 28Blood Specimen Collection 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26human papillomavirus vaccine, L1 type 16, 18 24Peripheral Blood Stem Cell Transplantation 23atezolizumab 22Oxaliplatin 22Pemetrexed 21Nivolumab 21Hyperthermic Intraperitoneal Chemotherapy 21Etoposide 21Immunoglobulin G 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × camrelizumab × Gynecologic × Clear all
NCT04680988 2025-08-05

A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Completed
194 enrolled
Gynecologic

Uterine Cervical Neoplasms, Recurrence

NCT03816553 2023-04-11

SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer

Sun Yat-sen University

Phase 2 Completed
45 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04047017 2021-07-30

GTN

Peking Union Medical College Hospital

Phase 2 Completed
20 enrolled
Gynecologic

Recurrence, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡